{"id":"https://openalex.org/W2014037006","doi":"https://doi.org/10.1016/s0957-4166(00)82340-x","title":"Unexpected effects of Lewis acids in the synthesis of optically pure 2\u2032-deoxy-3\u2032-oxacytidine nucleoside analogues","display_name":"Unexpected effects of Lewis acids in the synthesis of optically pure 2\u2032-deoxy-3\u2032-oxacytidine nucleoside analogues","publication_year":1993,"publication_date":"1993-02-01","ids":{"openalex":"https://openalex.org/W2014037006","doi":"https://doi.org/10.1016/s0957-4166(00)82340-x","mag":"2014037006"},"language":"en","primary_location":{"id":"doi:10.1016/s0957-4166(00)82340-x","doi":"https://doi.org/10.1016/s0957-4166(00)82340-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0957-4166(00)82340-x","pdf_url":null,"source":{"id":"https://openalex.org/S88152556","display_name":"Tetrahedron Asymmetry","issn_l":"0957-4166","issn":["0957-4166","1362-511X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron: Asymmetry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110622714","display_name":"Haolun Jin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haolun Jin","raw_affiliation_strings":["BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109427754","display_name":"H. L. A. TSE","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.L.Allan Tse","raw_affiliation_strings":["BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066224087","display_name":"Colleen A. Evans","orcid":"https://orcid.org/0000-0001-9566-2426","observed_orcids":["https://orcid.org/0000-0001-9566-2426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colleen A. Evans","raw_affiliation_strings":["BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054445318","display_name":"Tarek S. Mansour","orcid":"https://orcid.org/0000-0003-4782-697X","observed_orcids":["https://orcid.org/0000-0003-4782-697X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tarek S. Mansour","raw_affiliation_strings":["BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioChem Pharma Inc., 531 des Prairies Blvd., Laval, Quebec, Canada H7V 1B7","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002272967","display_name":"Christopher M. D. Beels","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher M. Beels","raw_affiliation_strings":["Chemical Development Department, Glaxo Group Research Ltd., Park Road, Ware, Hertfordshire, U.K. SG1 2OD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development Department, Glaxo Group Research Ltd., Park Road, Ware, Hertfordshire, U.K. SG1 2OD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078511914","display_name":"Paul D. Ravenscroft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Ravenscroft","raw_affiliation_strings":["Chemical Development Department, Glaxo Group Research Ltd., Park Road, Ware, Hertfordshire, U.K. SG1 2OD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development Department, Glaxo Group Research Ltd., Park Road, Ware, Hertfordshire, U.K. SG1 2OD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087275311","display_name":"David C. Humber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David C. Humber","raw_affiliation_strings":["Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103518743","display_name":"Martin F. Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin F. Jones","raw_affiliation_strings":["Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000346338","display_name":"Jeremy J. Payne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy J. Payne","raw_affiliation_strings":["Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025397575","display_name":"M. V. J. RAMSAY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael V.J. Ramsay","raw_affiliation_strings":["Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Glaxo Group Research Ltd., Greenford, Middlesex, U.K. UB6 0HE","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2572,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.73586012,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"4","issue":"2","first_page":"211","last_page":"214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.4934000074863434,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.4934000074863434,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.17970000207424164,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.14000000059604645,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lewis-acid","display_name":"Lewis acid","score":0.7889999747276306},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.949999988079071},{"id":"https://openalex.org/keywords/racemization","display_name":"racemization","score":0.7580000162124634},{"id":"https://openalex.org/keywords/ticl4","display_name":"titanium tetrachloride","score":0.8180000185966492},{"id":"https://openalex.org/keywords/tin-iv-chloride","display_name":"tin(IV) chloride","score":0.9470000267028809},{"id":"https://openalex.org/keywords/triflic-anhydride","display_name":"trifluoromethanesulfonic anhydride","score":0.7789999842643738},{"id":"https://openalex.org/keywords/diastereoselectivity","display_name":"diastereoselectivity","score":0.8870000243186951},{"id":"https://openalex.org/keywords/asymmetric-synthesis","display_name":"asymmetric synthesis","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C163638829","wikidata":"https://www.wikidata.org/wiki/Q900337","display_name":"Lewis acids and bases","level":3,"score":0.6382138729095459},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.5281964540481567},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5105644464492798},{"id":"https://openalex.org/C3019471444","wikidata":"https://www.wikidata.org/wiki/Q530648","display_name":"Optically active","level":2,"score":0.4851416051387787},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4467523396015167},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.26159465312957764},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.11359182000160217}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0957-4166(00)82340-x","doi":"https://doi.org/10.1016/s0957-4166(00)82340-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0957-4166(00)82340-x","pdf_url":null,"source":{"id":"https://openalex.org/S88152556","display_name":"Tetrahedron Asymmetry","issn_l":"0957-4166","issn":["0957-4166","1362-511X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron: Asymmetry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1964352719","https://openalex.org/W1995641234","https://openalex.org/W1999263043","https://openalex.org/W2019723308","https://openalex.org/W2021248556","https://openalex.org/W2029155148","https://openalex.org/W2046621752","https://openalex.org/W2050879289","https://openalex.org/W2051807087","https://openalex.org/W2105882139","https://openalex.org/W2149749704","https://openalex.org/W2152220420","https://openalex.org/W2165786297","https://openalex.org/W2950946613","https://openalex.org/W2951738192","https://openalex.org/W3004838919"],"related_works":["https://openalex.org/W2951077502","https://openalex.org/W2146546834","https://openalex.org/W2050746259","https://openalex.org/W2121617695","https://openalex.org/W2022660836","https://openalex.org/W7033902270","https://openalex.org/W2091563121","https://openalex.org/W2951063574","https://openalex.org/W2949764131","https://openalex.org/W2105882139"],"abstract_inverted_index":null,"counts_by_year":[{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2016-06-24T00:00:00"}